nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—SLC22A4—larynx—thyroid cancer	0.0402	0.323	CbGeAlD
Tiotropium—CYP3A4—Vandetanib—thyroid cancer	0.0344	0.286	CbGbCtD
Tiotropium—CYP2D6—Sorafenib—thyroid cancer	0.0326	0.271	CbGbCtD
Tiotropium—CYP3A4—Sorafenib—thyroid cancer	0.0207	0.173	CbGbCtD
Tiotropium—CYP2D6—Doxorubicin—thyroid cancer	0.0198	0.165	CbGbCtD
Tiotropium—Laryngitis—Vandetanib—thyroid cancer	0.0172	0.0228	CcSEcCtD
Tiotropium—Glaucoma—Vandetanib—thyroid cancer	0.0165	0.0218	CcSEcCtD
Tiotropium—Skin ulcer—Vandetanib—thyroid cancer	0.0159	0.0211	CcSEcCtD
Tiotropium—Cataract—Vandetanib—thyroid cancer	0.013	0.0172	CcSEcCtD
Tiotropium—CYP3A4—Doxorubicin—thyroid cancer	0.0126	0.105	CbGbCtD
Tiotropium—SLC22A4—neck—thyroid cancer	0.0107	0.0857	CbGeAlD
Tiotropium—Dysphonia—Sorafenib—thyroid cancer	0.0102	0.0135	CcSEcCtD
Tiotropium—Gastrooesophageal reflux disease—Sorafenib—thyroid cancer	0.00925	0.0123	CcSEcCtD
Tiotropium—Glossitis—Sorafenib—thyroid cancer	0.00907	0.012	CcSEcCtD
Tiotropium—Dehydration—Vandetanib—thyroid cancer	0.00836	0.0111	CcSEcCtD
Tiotropium—Dry skin—Vandetanib—thyroid cancer	0.00824	0.0109	CcSEcCtD
Tiotropium—Influenza like illness—Sorafenib—thyroid cancer	0.00812	0.0107	CcSEcCtD
Tiotropium—Dysphagia—Vandetanib—thyroid cancer	0.00777	0.0103	CcSEcCtD
Tiotropium—Mouth ulceration—Sorafenib—thyroid cancer	0.00756	0.01	CcSEcCtD
Tiotropium—CHRM1—saliva-secreting gland—thyroid cancer	0.00735	0.059	CbGeAlD
Tiotropium—Dysuria—Vandetanib—thyroid cancer	0.00727	0.00962	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00723	0.00957	CcSEcCtD
Tiotropium—Hyperglycaemia—Vandetanib—thyroid cancer	0.00701	0.00928	CcSEcCtD
Tiotropium—Renal failure—Vandetanib—thyroid cancer	0.00681	0.00902	CcSEcCtD
Tiotropium—Stomatitis—Vandetanib—thyroid cancer	0.00676	0.00894	CcSEcCtD
Tiotropium—Urinary tract infection—Vandetanib—thyroid cancer	0.00674	0.00892	CcSEcCtD
Tiotropium—Ulcerative stomatitis—Epirubicin—thyroid cancer	0.00669	0.00886	CcSEcCtD
Tiotropium—CHRM3—saliva-secreting gland—thyroid cancer	0.00657	0.0528	CbGeAlD
Tiotropium—Epistaxis—Vandetanib—thyroid cancer	0.00654	0.00866	CcSEcCtD
Tiotropium—Sinusitis—Vandetanib—thyroid cancer	0.0065	0.00861	CcSEcCtD
Tiotropium—SLC22A4—trachea—thyroid cancer	0.00642	0.0516	CbGeAlD
Tiotropium—CHRM5—head—thyroid cancer	0.00636	0.0511	CbGeAlD
Tiotropium—Ulcerative stomatitis—Doxorubicin—thyroid cancer	0.00619	0.0082	CcSEcCtD
Tiotropium—Urinary tract disorder—Vandetanib—thyroid cancer	0.00615	0.00814	CcSEcCtD
Tiotropium—Urethral disorder—Vandetanib—thyroid cancer	0.0061	0.00808	CcSEcCtD
Tiotropium—Pain in extremity—Sorafenib—thyroid cancer	0.00607	0.00803	CcSEcCtD
Tiotropium—Visual impairment—Vandetanib—thyroid cancer	0.006	0.00794	CcSEcCtD
Tiotropium—Eye disorder—Vandetanib—thyroid cancer	0.00582	0.0077	CcSEcCtD
Tiotropium—CHRM1—trachea—thyroid cancer	0.00567	0.0455	CbGeAlD
Tiotropium—Angiopathy—Vandetanib—thyroid cancer	0.00565	0.00747	CcSEcCtD
Tiotropium—Dehydration—Sorafenib—thyroid cancer	0.00564	0.00747	CcSEcCtD
Tiotropium—Mediastinal disorder—Vandetanib—thyroid cancer	0.00561	0.00742	CcSEcCtD
Tiotropium—Dry skin—Sorafenib—thyroid cancer	0.00556	0.00736	CcSEcCtD
Tiotropium—Arrhythmia—Vandetanib—thyroid cancer	0.00556	0.00736	CcSEcCtD
Tiotropium—SLC22A5—saliva-secreting gland—thyroid cancer	0.00551	0.0442	CbGeAlD
Tiotropium—Mental disorder—Vandetanib—thyroid cancer	0.00545	0.00722	CcSEcCtD
Tiotropium—Malnutrition—Vandetanib—thyroid cancer	0.00542	0.00717	CcSEcCtD
Tiotropium—Dysphagia—Sorafenib—thyroid cancer	0.00524	0.00694	CcSEcCtD
Tiotropium—Vision blurred—Vandetanib—thyroid cancer	0.0051	0.00676	CcSEcCtD
Tiotropium—SLC22A4—thyroid gland—thyroid cancer	0.00508	0.0408	CbGeAlD
Tiotropium—Oral candidiasis—Epirubicin—thyroid cancer	0.00486	0.00644	CcSEcCtD
Tiotropium—Loss of consciousness—Vandetanib—thyroid cancer	0.00476	0.0063	CcSEcCtD
Tiotropium—Cough—Vandetanib—thyroid cancer	0.00473	0.00626	CcSEcCtD
Tiotropium—Hypertension—Vandetanib—thyroid cancer	0.00468	0.00619	CcSEcCtD
Tiotropium—Chest pain—Vandetanib—thyroid cancer	0.00461	0.00611	CcSEcCtD
Tiotropium—Arthralgia—Vandetanib—thyroid cancer	0.00461	0.00611	CcSEcCtD
Tiotropium—Renal failure—Sorafenib—thyroid cancer	0.0046	0.00608	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00458	0.00606	CcSEcCtD
Tiotropium—Stomatitis—Sorafenib—thyroid cancer	0.00456	0.00603	CcSEcCtD
Tiotropium—Dry mouth—Vandetanib—thyroid cancer	0.00451	0.00597	CcSEcCtD
Tiotropium—Oral candidiasis—Doxorubicin—thyroid cancer	0.0045	0.00596	CcSEcCtD
Tiotropium—Oedema—Vandetanib—thyroid cancer	0.00442	0.00585	CcSEcCtD
Tiotropium—Epistaxis—Sorafenib—thyroid cancer	0.00441	0.00584	CcSEcCtD
Tiotropium—Infection—Vandetanib—thyroid cancer	0.00439	0.00581	CcSEcCtD
Tiotropium—CHRM2—head—thyroid cancer	0.00437	0.0351	CbGeAlD
Tiotropium—Nervous system disorder—Vandetanib—thyroid cancer	0.00434	0.00574	CcSEcCtD
Tiotropium—Skin disorder—Vandetanib—thyroid cancer	0.00429	0.00568	CcSEcCtD
Tiotropium—Laryngitis—Epirubicin—thyroid cancer	0.00429	0.00567	CcSEcCtD
Tiotropium—SLC22A5—trachea—thyroid cancer	0.00425	0.0341	CbGeAlD
Tiotropium—Urinary tract disorder—Sorafenib—thyroid cancer	0.00415	0.00549	CcSEcCtD
Tiotropium—Connective tissue disorder—Sorafenib—thyroid cancer	0.00412	0.00546	CcSEcCtD
Tiotropium—Urethral disorder—Sorafenib—thyroid cancer	0.00411	0.00545	CcSEcCtD
Tiotropium—Herpes zoster—Epirubicin—thyroid cancer	0.0041	0.00543	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00403	0.00533	CcSEcCtD
Tiotropium—CHRM3—thyroid gland—thyroid cancer	0.00401	0.0322	CbGeAlD
Tiotropium—Insomnia—Vandetanib—thyroid cancer	0.004	0.00529	CcSEcCtD
Tiotropium—CHRM1—head—thyroid cancer	0.00398	0.0319	CbGeAlD
Tiotropium—Paraesthesia—Vandetanib—thyroid cancer	0.00397	0.00526	CcSEcCtD
Tiotropium—Skin ulcer—Epirubicin—thyroid cancer	0.00397	0.00525	CcSEcCtD
Tiotropium—Laryngitis—Doxorubicin—thyroid cancer	0.00397	0.00525	CcSEcCtD
Tiotropium—Gingivitis—Epirubicin—thyroid cancer	0.00394	0.00521	CcSEcCtD
Tiotropium—Dyspepsia—Vandetanib—thyroid cancer	0.00389	0.00515	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00382	0.00505	CcSEcCtD
Tiotropium—Angiopathy—Sorafenib—thyroid cancer	0.00381	0.00504	CcSEcCtD
Tiotropium—Herpes zoster—Doxorubicin—thyroid cancer	0.0038	0.00503	CcSEcCtD
Tiotropium—Immune system disorder—Sorafenib—thyroid cancer	0.00379	0.00502	CcSEcCtD
Tiotropium—Mediastinal disorder—Sorafenib—thyroid cancer	0.00378	0.00501	CcSEcCtD
Tiotropium—Constipation—Vandetanib—thyroid cancer	0.00378	0.005	CcSEcCtD
Tiotropium—Dysphonia—Epirubicin—thyroid cancer	0.00375	0.00497	CcSEcCtD
Tiotropium—Arrhythmia—Sorafenib—thyroid cancer	0.00375	0.00496	CcSEcCtD
Tiotropium—Mental disorder—Sorafenib—thyroid cancer	0.00368	0.00487	CcSEcCtD
Tiotropium—Skin ulcer—Doxorubicin—thyroid cancer	0.00367	0.00486	CcSEcCtD
Tiotropium—Malnutrition—Sorafenib—thyroid cancer	0.00365	0.00484	CcSEcCtD
Tiotropium—Gingivitis—Doxorubicin—thyroid cancer	0.00364	0.00482	CcSEcCtD
Tiotropium—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00361	0.00479	CcSEcCtD
Tiotropium—CHRM3—head—thyroid cancer	0.00356	0.0286	CbGeAlD
Tiotropium—Abdominal pain—Vandetanib—thyroid cancer	0.00349	0.00463	CcSEcCtD
Tiotropium—Dysphonia—Doxorubicin—thyroid cancer	0.00347	0.0046	CcSEcCtD
Tiotropium—SLC22A5—thyroid gland—thyroid cancer	0.00336	0.027	CbGeAlD
Tiotropium—Glossitis—Epirubicin—thyroid cancer	0.00335	0.00444	CcSEcCtD
Tiotropium—Angioedema—Sorafenib—thyroid cancer	0.00334	0.00442	CcSEcCtD
Tiotropium—Syncope—Sorafenib—thyroid cancer	0.00328	0.00434	CcSEcCtD
Tiotropium—Bone pain—Epirubicin—thyroid cancer	0.00322	0.00427	CcSEcCtD
Tiotropium—Loss of consciousness—Sorafenib—thyroid cancer	0.00321	0.00425	CcSEcCtD
Tiotropium—Cough—Sorafenib—thyroid cancer	0.00319	0.00422	CcSEcCtD
Tiotropium—SLC22A4—lymph node—thyroid cancer	0.00316	0.0253	CbGeAlD
Tiotropium—Hypertension—Sorafenib—thyroid cancer	0.00315	0.00418	CcSEcCtD
Tiotropium—Pruritus—Vandetanib—thyroid cancer	0.00313	0.00414	CcSEcCtD
Tiotropium—Arthralgia—Sorafenib—thyroid cancer	0.00311	0.00412	CcSEcCtD
Tiotropium—Myalgia—Sorafenib—thyroid cancer	0.00311	0.00412	CcSEcCtD
Tiotropium—Glossitis—Doxorubicin—thyroid cancer	0.0031	0.00411	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00309	0.00409	CcSEcCtD
Tiotropium—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00309	0.00409	CcSEcCtD
Tiotropium—Dry mouth—Sorafenib—thyroid cancer	0.00304	0.00403	CcSEcCtD
Tiotropium—Influenza like illness—Epirubicin—thyroid cancer	0.003	0.00397	CcSEcCtD
Tiotropium—Bone pain—Doxorubicin—thyroid cancer	0.00298	0.00395	CcSEcCtD
Tiotropium—Infection—Sorafenib—thyroid cancer	0.00296	0.00392	CcSEcCtD
Tiotropium—Candida infection—Epirubicin—thyroid cancer	0.00295	0.0039	CcSEcCtD
Tiotropium—Shock—Sorafenib—thyroid cancer	0.00293	0.00388	CcSEcCtD
Tiotropium—Nervous system disorder—Sorafenib—thyroid cancer	0.00292	0.00387	CcSEcCtD
Tiotropium—Dizziness—Vandetanib—thyroid cancer	0.00292	0.00387	CcSEcCtD
Tiotropium—Skin disorder—Sorafenib—thyroid cancer	0.0029	0.00383	CcSEcCtD
Tiotropium—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00286	0.00378	CcSEcCtD
Tiotropium—Vomiting—Vandetanib—thyroid cancer	0.00281	0.00372	CcSEcCtD
Tiotropium—Mouth ulceration—Epirubicin—thyroid cancer	0.00279	0.0037	CcSEcCtD
Tiotropium—Rash—Vandetanib—thyroid cancer	0.00279	0.00369	CcSEcCtD
Tiotropium—Dermatitis—Vandetanib—thyroid cancer	0.00278	0.00369	CcSEcCtD
Tiotropium—Influenza like illness—Doxorubicin—thyroid cancer	0.00278	0.00367	CcSEcCtD
Tiotropium—Headache—Vandetanib—thyroid cancer	0.00277	0.00367	CcSEcCtD
Tiotropium—Candida infection—Doxorubicin—thyroid cancer	0.00273	0.00361	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00272	0.0036	CcSEcCtD
Tiotropium—Nausea—Vandetanib—thyroid cancer	0.00263	0.00348	CcSEcCtD
Tiotropium—Dyspepsia—Sorafenib—thyroid cancer	0.00263	0.00348	CcSEcCtD
Tiotropium—Mouth ulceration—Doxorubicin—thyroid cancer	0.00258	0.00342	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00257	0.00341	CcSEcCtD
Tiotropium—Constipation—Sorafenib—thyroid cancer	0.00255	0.00338	CcSEcCtD
Tiotropium—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00244	0.00323	CcSEcCtD
Tiotropium—Urticaria—Sorafenib—thyroid cancer	0.00237	0.00314	CcSEcCtD
Tiotropium—Abdominal pain—Sorafenib—thyroid cancer	0.00236	0.00312	CcSEcCtD
Tiotropium—Pain in extremity—Epirubicin—thyroid cancer	0.00224	0.00297	CcSEcCtD
Tiotropium—Hypersensitivity—Sorafenib—thyroid cancer	0.0022	0.00291	CcSEcCtD
Tiotropium—Pruritus—Sorafenib—thyroid cancer	0.00211	0.00279	CcSEcCtD
Tiotropium—SLC22A5—lymph node—thyroid cancer	0.00209	0.0168	CbGeAlD
Tiotropium—Dehydration—Epirubicin—thyroid cancer	0.00209	0.00276	CcSEcCtD
Tiotropium—Pain in extremity—Doxorubicin—thyroid cancer	0.00207	0.00275	CcSEcCtD
Tiotropium—Dry skin—Epirubicin—thyroid cancer	0.00206	0.00272	CcSEcCtD
Tiotropium—Dizziness—Sorafenib—thyroid cancer	0.00197	0.00261	CcSEcCtD
Tiotropium—Dysphagia—Epirubicin—thyroid cancer	0.00194	0.00257	CcSEcCtD
Tiotropium—Dehydration—Doxorubicin—thyroid cancer	0.00193	0.00255	CcSEcCtD
Tiotropium—CYP2D6—head—thyroid cancer	0.00192	0.0154	CbGeAlD
Tiotropium—Dry skin—Doxorubicin—thyroid cancer	0.0019	0.00252	CcSEcCtD
Tiotropium—Vomiting—Sorafenib—thyroid cancer	0.0019	0.00251	CcSEcCtD
Tiotropium—Angina pectoris—Epirubicin—thyroid cancer	0.00189	0.0025	CcSEcCtD
Tiotropium—Rash—Sorafenib—thyroid cancer	0.00188	0.00249	CcSEcCtD
Tiotropium—Dermatitis—Sorafenib—thyroid cancer	0.00188	0.00249	CcSEcCtD
Tiotropium—Headache—Sorafenib—thyroid cancer	0.00187	0.00247	CcSEcCtD
Tiotropium—Dysuria—Epirubicin—thyroid cancer	0.00181	0.0024	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.0018	0.00238	CcSEcCtD
Tiotropium—Dysphagia—Doxorubicin—thyroid cancer	0.00179	0.00237	CcSEcCtD
Tiotropium—Nausea—Sorafenib—thyroid cancer	0.00177	0.00235	CcSEcCtD
Tiotropium—Hyperglycaemia—Epirubicin—thyroid cancer	0.00175	0.00231	CcSEcCtD
Tiotropium—Angina pectoris—Doxorubicin—thyroid cancer	0.00175	0.00231	CcSEcCtD
Tiotropium—Renal failure—Epirubicin—thyroid cancer	0.0017	0.00225	CcSEcCtD
Tiotropium—Stomatitis—Epirubicin—thyroid cancer	0.00168	0.00223	CcSEcCtD
Tiotropium—Urinary tract infection—Epirubicin—thyroid cancer	0.00168	0.00222	CcSEcCtD
Tiotropium—Dysuria—Doxorubicin—thyroid cancer	0.00168	0.00222	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00167	0.00221	CcSEcCtD
Tiotropium—Epistaxis—Epirubicin—thyroid cancer	0.00163	0.00216	CcSEcCtD
Tiotropium—Sinusitis—Epirubicin—thyroid cancer	0.00162	0.00215	CcSEcCtD
Tiotropium—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00162	0.00214	CcSEcCtD
Tiotropium—Renal failure—Doxorubicin—thyroid cancer	0.00157	0.00208	CcSEcCtD
Tiotropium—Stomatitis—Doxorubicin—thyroid cancer	0.00156	0.00206	CcSEcCtD
Tiotropium—Rhinitis—Epirubicin—thyroid cancer	0.00156	0.00206	CcSEcCtD
Tiotropium—Urinary tract infection—Doxorubicin—thyroid cancer	0.00155	0.00206	CcSEcCtD
Tiotropium—Pharyngitis—Epirubicin—thyroid cancer	0.00154	0.00204	CcSEcCtD
Tiotropium—Urinary tract disorder—Epirubicin—thyroid cancer	0.00153	0.00203	CcSEcCtD
Tiotropium—Oedema peripheral—Epirubicin—thyroid cancer	0.00153	0.00202	CcSEcCtD
Tiotropium—Connective tissue disorder—Epirubicin—thyroid cancer	0.00152	0.00202	CcSEcCtD
Tiotropium—Urethral disorder—Epirubicin—thyroid cancer	0.00152	0.00201	CcSEcCtD
Tiotropium—Epistaxis—Doxorubicin—thyroid cancer	0.00151	0.002	CcSEcCtD
Tiotropium—Sinusitis—Doxorubicin—thyroid cancer	0.0015	0.00199	CcSEcCtD
Tiotropium—Visual impairment—Epirubicin—thyroid cancer	0.00149	0.00198	CcSEcCtD
Tiotropium—Eye disorder—Epirubicin—thyroid cancer	0.00145	0.00192	CcSEcCtD
Tiotropium—Rhinitis—Doxorubicin—thyroid cancer	0.00144	0.0019	CcSEcCtD
Tiotropium—Pharyngitis—Doxorubicin—thyroid cancer	0.00142	0.00189	CcSEcCtD
Tiotropium—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00142	0.00188	CcSEcCtD
Tiotropium—Oedema peripheral—Doxorubicin—thyroid cancer	0.00141	0.00187	CcSEcCtD
Tiotropium—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00141	0.00187	CcSEcCtD
Tiotropium—Angiopathy—Epirubicin—thyroid cancer	0.00141	0.00186	CcSEcCtD
Tiotropium—Urethral disorder—Doxorubicin—thyroid cancer	0.00141	0.00186	CcSEcCtD
Tiotropium—Immune system disorder—Epirubicin—thyroid cancer	0.0014	0.00185	CcSEcCtD
Tiotropium—Mediastinal disorder—Epirubicin—thyroid cancer	0.0014	0.00185	CcSEcCtD
Tiotropium—Arrhythmia—Epirubicin—thyroid cancer	0.00139	0.00183	CcSEcCtD
Tiotropium—Visual impairment—Doxorubicin—thyroid cancer	0.00138	0.00183	CcSEcCtD
Tiotropium—Mental disorder—Epirubicin—thyroid cancer	0.00136	0.0018	CcSEcCtD
Tiotropium—Malnutrition—Epirubicin—thyroid cancer	0.00135	0.00179	CcSEcCtD
Tiotropium—Eye disorder—Doxorubicin—thyroid cancer	0.00134	0.00178	CcSEcCtD
Tiotropium—Back pain—Epirubicin—thyroid cancer	0.00131	0.00173	CcSEcCtD
Tiotropium—Angiopathy—Doxorubicin—thyroid cancer	0.0013	0.00172	CcSEcCtD
Tiotropium—Immune system disorder—Doxorubicin—thyroid cancer	0.0013	0.00172	CcSEcCtD
Tiotropium—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00129	0.00171	CcSEcCtD
Tiotropium—Arrhythmia—Doxorubicin—thyroid cancer	0.00128	0.0017	CcSEcCtD
Tiotropium—Vision blurred—Epirubicin—thyroid cancer	0.00127	0.00168	CcSEcCtD
Tiotropium—Mental disorder—Doxorubicin—thyroid cancer	0.00126	0.00166	CcSEcCtD
Tiotropium—Malnutrition—Doxorubicin—thyroid cancer	0.00125	0.00165	CcSEcCtD
Tiotropium—Syncope—Epirubicin—thyroid cancer	0.00121	0.0016	CcSEcCtD
Tiotropium—Back pain—Doxorubicin—thyroid cancer	0.00121	0.0016	CcSEcCtD
Tiotropium—Palpitations—Epirubicin—thyroid cancer	0.00119	0.00158	CcSEcCtD
Tiotropium—Loss of consciousness—Epirubicin—thyroid cancer	0.00119	0.00157	CcSEcCtD
Tiotropium—Cough—Epirubicin—thyroid cancer	0.00118	0.00156	CcSEcCtD
Tiotropium—Vision blurred—Doxorubicin—thyroid cancer	0.00118	0.00156	CcSEcCtD
Tiotropium—Hypertension—Epirubicin—thyroid cancer	0.00117	0.00154	CcSEcCtD
Tiotropium—Myalgia—Epirubicin—thyroid cancer	0.00115	0.00152	CcSEcCtD
Tiotropium—Arthralgia—Epirubicin—thyroid cancer	0.00115	0.00152	CcSEcCtD
Tiotropium—Chest pain—Epirubicin—thyroid cancer	0.00115	0.00152	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00114	0.00151	CcSEcCtD
Tiotropium—Dry mouth—Epirubicin—thyroid cancer	0.00112	0.00149	CcSEcCtD
Tiotropium—Syncope—Doxorubicin—thyroid cancer	0.00112	0.00148	CcSEcCtD
Tiotropium—Palpitations—Doxorubicin—thyroid cancer	0.0011	0.00146	CcSEcCtD
Tiotropium—Oedema—Epirubicin—thyroid cancer	0.0011	0.00146	CcSEcCtD
Tiotropium—Loss of consciousness—Doxorubicin—thyroid cancer	0.0011	0.00145	CcSEcCtD
Tiotropium—Infection—Epirubicin—thyroid cancer	0.00109	0.00145	CcSEcCtD
Tiotropium—Cough—Doxorubicin—thyroid cancer	0.00109	0.00144	CcSEcCtD
Tiotropium—Shock—Epirubicin—thyroid cancer	0.00108	0.00144	CcSEcCtD
Tiotropium—Nervous system disorder—Epirubicin—thyroid cancer	0.00108	0.00143	CcSEcCtD
Tiotropium—Hypertension—Doxorubicin—thyroid cancer	0.00108	0.00143	CcSEcCtD
Tiotropium—Tachycardia—Epirubicin—thyroid cancer	0.00108	0.00142	CcSEcCtD
Tiotropium—Skin disorder—Epirubicin—thyroid cancer	0.00107	0.00142	CcSEcCtD
Tiotropium—Arthralgia—Doxorubicin—thyroid cancer	0.00106	0.00141	CcSEcCtD
Tiotropium—Chest pain—Doxorubicin—thyroid cancer	0.00106	0.00141	CcSEcCtD
Tiotropium—Myalgia—Doxorubicin—thyroid cancer	0.00106	0.00141	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00106	0.0014	CcSEcCtD
Tiotropium—Dry mouth—Doxorubicin—thyroid cancer	0.00104	0.00138	CcSEcCtD
Tiotropium—Oedema—Doxorubicin—thyroid cancer	0.00102	0.00135	CcSEcCtD
Tiotropium—Infection—Doxorubicin—thyroid cancer	0.00101	0.00134	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.001	0.00133	CcSEcCtD
Tiotropium—Shock—Doxorubicin—thyroid cancer	0.001	0.00133	CcSEcCtD
Tiotropium—Nervous system disorder—Doxorubicin—thyroid cancer	0.001	0.00132	CcSEcCtD
Tiotropium—Insomnia—Epirubicin—thyroid cancer	0.000997	0.00132	CcSEcCtD
Tiotropium—Tachycardia—Doxorubicin—thyroid cancer	0.000995	0.00132	CcSEcCtD
Tiotropium—Skin disorder—Doxorubicin—thyroid cancer	0.000991	0.00131	CcSEcCtD
Tiotropium—Paraesthesia—Epirubicin—thyroid cancer	0.00099	0.00131	CcSEcCtD
Tiotropium—Dyspepsia—Epirubicin—thyroid cancer	0.00097	0.00128	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000951	0.00126	CcSEcCtD
Tiotropium—Constipation—Epirubicin—thyroid cancer	0.000942	0.00125	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000929	0.00123	CcSEcCtD
Tiotropium—Insomnia—Doxorubicin—thyroid cancer	0.000922	0.00122	CcSEcCtD
Tiotropium—Paraesthesia—Doxorubicin—thyroid cancer	0.000916	0.00121	CcSEcCtD
Tiotropium—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000901	0.00119	CcSEcCtD
Tiotropium—Dyspepsia—Doxorubicin—thyroid cancer	0.000898	0.00119	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00088	0.00117	CcSEcCtD
Tiotropium—Urticaria—Epirubicin—thyroid cancer	0.000876	0.00116	CcSEcCtD
Tiotropium—Constipation—Doxorubicin—thyroid cancer	0.000872	0.00115	CcSEcCtD
Tiotropium—Abdominal pain—Epirubicin—thyroid cancer	0.000871	0.00115	CcSEcCtD
Tiotropium—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000834	0.0011	CcSEcCtD
Tiotropium—Hypersensitivity—Epirubicin—thyroid cancer	0.000812	0.00107	CcSEcCtD
Tiotropium—Urticaria—Doxorubicin—thyroid cancer	0.00081	0.00107	CcSEcCtD
Tiotropium—Abdominal pain—Doxorubicin—thyroid cancer	0.000806	0.00107	CcSEcCtD
Tiotropium—Pruritus—Epirubicin—thyroid cancer	0.00078	0.00103	CcSEcCtD
Tiotropium—Hypersensitivity—Doxorubicin—thyroid cancer	0.000751	0.000995	CcSEcCtD
Tiotropium—Dizziness—Epirubicin—thyroid cancer	0.000729	0.000965	CcSEcCtD
Tiotropium—Pruritus—Doxorubicin—thyroid cancer	0.000721	0.000955	CcSEcCtD
Tiotropium—Vomiting—Epirubicin—thyroid cancer	0.000701	0.000928	CcSEcCtD
Tiotropium—Rash—Epirubicin—thyroid cancer	0.000695	0.00092	CcSEcCtD
Tiotropium—Dermatitis—Epirubicin—thyroid cancer	0.000694	0.000919	CcSEcCtD
Tiotropium—Headache—Epirubicin—thyroid cancer	0.00069	0.000914	CcSEcCtD
Tiotropium—Dizziness—Doxorubicin—thyroid cancer	0.000674	0.000893	CcSEcCtD
Tiotropium—Nausea—Epirubicin—thyroid cancer	0.000655	0.000867	CcSEcCtD
Tiotropium—Vomiting—Doxorubicin—thyroid cancer	0.000648	0.000858	CcSEcCtD
Tiotropium—Rash—Doxorubicin—thyroid cancer	0.000643	0.000851	CcSEcCtD
Tiotropium—Dermatitis—Doxorubicin—thyroid cancer	0.000642	0.00085	CcSEcCtD
Tiotropium—Headache—Doxorubicin—thyroid cancer	0.000639	0.000846	CcSEcCtD
Tiotropium—Nausea—Doxorubicin—thyroid cancer	0.000606	0.000802	CcSEcCtD
